
Sign up to save your podcasts
Or


Key Takeaways
Why the social media addiction trial against Meta may be trending toward a plaintiff verdict
How the UK warning on semaglutide could strengthen weight loss drug injury claims in the U.S.
What the upcoming Daubert hearings mean for the future of the hair relaxer MDL
The 90 day opt out window in the Roundup Missouri class action and what firms must do now
How regulatory warnings and expert testimony shape mass tort litigation timelines
By Jon & MarcKey Takeaways
Why the social media addiction trial against Meta may be trending toward a plaintiff verdict
How the UK warning on semaglutide could strengthen weight loss drug injury claims in the U.S.
What the upcoming Daubert hearings mean for the future of the hair relaxer MDL
The 90 day opt out window in the Roundup Missouri class action and what firms must do now
How regulatory warnings and expert testimony shape mass tort litigation timelines